EGFR reporting in stage IV adenocarcinoma of the lung: Demographic predictors of EGFR testing and survival.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.9100
Abstract: 9100Background: Tyrosine Kinase inhibitors (TKI) have changed the treatment paradigm in patients with stage IV adenocarcinoma of the lung (AdenoCa) harboring epidermal growth factor receptor (EGFR)... read more here.
Keywords: adenocarcinoma lung; reporting stage; stage adenocarcinoma; egfr reporting ... See more keywords